| Mark K Moore, MD | |
|
601 W Hwy 6, 101, Waco, TX 76710-5575 | |
| (254) 772-5454 | |
| (254) 772-6464 |
| Full Name | Mark K Moore |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 601 W Hwy 6, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255445458 | NPI | - | NPPES |
| 037091803 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | J9911 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health Alliance | 6305731068 | 129 |
News Archive
A recent study by Grassi et al. has concluded that blood glucose control in diabetes patients who inject insulin can be improved through better injection technique, which includes switching patients to 4 mm pen needles.
Dietary and fitness habits have been shown to play a significant role in erectile performance and could improve erectile performance.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
› Verified 7 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
A recent study by Grassi et al. has concluded that blood glucose control in diabetes patients who inject insulin can be improved through better injection technique, which includes switching patients to 4 mm pen needles.
Dietary and fitness habits have been shown to play a significant role in erectile performance and could improve erectile performance.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark K Moore, MD Po Box 18962, Belfast, ME 04915-4084 Ph: (800) 566-5050 | Mark K Moore, MD 601 W Hwy 6, 101, Waco, TX 76710-5575 Ph: (254) 772-5454 |
News Archive
A recent study by Grassi et al. has concluded that blood glucose control in diabetes patients who inject insulin can be improved through better injection technique, which includes switching patients to 4 mm pen needles.
Dietary and fitness habits have been shown to play a significant role in erectile performance and could improve erectile performance.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
In the United States, a baby is born with a facial cleft every hour, of every day of the year! Such birth defects result from both gene mutations and environmental insults. PRDM16 is a transcription factor originally described as being aberrantly activated in specific types of leukemia's, and more recently as a master regulator of brown adipose tissue differentiation.
› Verified 7 days ago
Dr. Carl Anthony Dunn, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7700 Fish Pond Rd, Waco, TX 76710 Phone: 254-741-4444 | |
Zachery Pettis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 W State Highway 6 Ste 101, Waco, TX 76710 Phone: 254-772-5454 | |
Robert W Grayson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7030 New Sanger Ave, Ste 204, Waco, TX 76712 Phone: 254-753-3190 Fax: 254-755-8515 | |
Dr. Jeff D. Chancellor, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7700 Fish Pond Rd, Waco, TX 76710 Phone: 254-741-4444 | |
Lucy K Villarreal, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 405 Londonderry, Ste 309, Waco, TX 76712 Phone: 254-741-1860 Fax: 254-741-1249 | |
Dr. John Bagnasco, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 W Hwy 6, Ste 101, Waco, TX 76710 Phone: 254-772-5454 Fax: 254-772-6464 | |
Dr. James Huddleston, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 120 Hillcrest Medical Blvd Ste 201-2, Waco, TX 76712 Phone: 254-399-6000 Fax: 254-399-6018 |